Novo Nordisk cuts ties with Hims & Hers after Wegovy dispute
Novo Nordisk is ending its collaboration with Hims & Hers Health due to concerns about the company’s sales and marketing practices related to the weight-loss drug Wegovy.
As recently as April, Novo Nordisk announced that Wegovy would be made available through the Hims & Hers telehealth platform. However, the decision to terminate the partnership just over a month later stems from concerns that the company has been distributing illegitimate versions of Wegovy. According to the Danish pharmaceutical giant, Hims &a...
Vill du få åtkomst till allt?
Prova 30 dagar för 0 kr.
Inga bindningstider eller kortuppgifter krävs.
Prova nu
Köp en prenumeration
Utforska våra prenumerationslösningar och välj den som passar dina behov.
Välj din prenumeration